Arkolith/Insider Trading/RYTM/Form 4

Jean Christophe

DirectorRHYTHM PHARMACEUTICALS, INC. (RYTM) · full profile →Form 4 · filed Jun 25, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 23, 2026Option exercise(M)5K——12K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 24, 2026Grant(A)4K—$04K
Jun 24, 2026Grant(A)2K—$02K
Jun 23, 2026Option exercise(M)5K—$00

Transaction Codes

M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-077867) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML